Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KRRO
#3224
Korro Bio, Inc. Common Stock
12.130
0
+4.39%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+4.39%
Mudança mensal
+6.22%
Mudança em 6 meses
-68.82%
Mudança anual
-68.82%
Fechamento anterior
11.620
0
Open
12.130
0
Bid
Ask
Low
12.130
0
High
12.130
0
Volume
27
Mercados
Ações
Cuidados de saúde
KRRO
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
34.18 M
34.98 M
35.29 M
8.02 M
9.39 M
—
Valuation ratios
Enterprise value
—
—
—
228.05 M
301.79 M
911.66 M
Price to earnings ratio
—
—
—
-0.93
-4.06
-12.29
Price to sales ratio
—
—
—
—
149.54
—
Price to cash flow ratio
—
—
—
1.12
5.65
16.48
Price to book ratio
—
—
—
0.14
0.49
0.74
Enterprise value to EBITDA ratio
—
—
—
-2.81
—
—
Profitability ratios
Return on assets %
0.1
0.46
0.67
0.37
0.37
0.46
Return on equity %
0.14
0.65
1.18
0.48
0.52
0.71
Return on invested capital %
-211.02
-626.33
-671.01
-699.18
-487.96
-380.89
Gross margin %
100
100
—
—
100
400
Operating margin %
-74.49
-597.32
—
—
-4 047.12
-5 623.72
EBITDA margin %
—
—
—
—
—
—
Net margin %
71.68
601.98
—
—
3 680.36
5 272.64
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.45
11.79
4.16
8.87
8.79
30.89
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.15
0.06
0
0
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.06
0.08
0.03
—
—
—
Long term debt to total equity ratio
0.04
0.03
0.01
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
44
6.73
7.32
EBIT per share
—
—
—
-55.28
—
—
EBITDA per share
—
—
—
-52.97
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
108.64
14.14
38.6
Net current asset value per share
—
—
—
112.94
14.74
49.06
Tangible book value per share
—
—
—
350.43
77.75
315.52
Working capital per share
—
—
—
100.2
13.07
42.62
Book value per share
—
—
—
350.43
77.75
315.52
Notícias
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
Clear Street eleva classificação da Korro Bio com base no potencial do programa de hiperamonemia
Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential
Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?
H.C. Wainwright eleva recomendação das ações da Korro Bio para compra
Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential
Piper Sandler eleva classificação das ações da Korro Bio para acima da média com tratamento para UCD
Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment
Chardan Capital eleva Korro Bio para compra devido ao potencial do KRRO-121
Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential
Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow (NASDAQ:KRRO) 2026-01-28
Raymond James mantém recomendação neutra para ações da Korro Bio